Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro.
Ontology highlight
ABSTRACT: Directed differentiation of human pluripotent stem cells into functional insulin-producing beta-like cells holds great promise for cell replacement therapy for patients suffering from diabetes. This approach also offers the unique opportunity to study otherwise inaccessible aspects of human beta cell development and function in vitro. Here, we show that current pancreatic progenitor differentiation protocols promote precocious endocrine commitment, ultimately resulting in the generation of non-functional polyhormonal cells. Omission of commonly used BMP inhibitors during pancreatic specification prevents precocious endocrine formation while treatment with retinoic acid followed by combined EGF/KGF efficiently generates both PDX1(+) and subsequent PDX1(+)/NKX6.1(+) pancreatic progenitor pop
SUBMITTER: Russ HA
PROVIDER: S-EPMC4516429 | biostudies-literature | 2015 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA